The North America Scar Treatment Market would witness market growth of 8.2% CAGR during the forecast period (2022-2028).
Deeper scars may be treated in a number of different ways, depending on the individual and the circumstances. These procedures may include the use of dermabrasion, excision, laser surgery, or skin transplants. A skin transplant involves the use of skin taken from another part of your body by a surgeon. People who have been burned often get this treatment. Scarring may be a concern for function; however, surgery can assist in addressing the issue and improve function if it's severe enough.
If a person just had surgery that resulted in scarring, it is advised to wait at least a year before deciding how to treat the scars before making any treatment choices. The majority of scars eventually lighten in color and become less apparent as time passes. In addition, the scar markings, like stretch marks and hypertrophic scars, are the ones responsible for the appearance of dwindling. A further factor that helps the expansion of the industry is the growing popularity of skin piercing. It is possible for a keloid scar to develop at the site of the skin piercing.
A further factor that contributes to the expansion of the market is the rising incidence of acne scars. Scarring from face acne may sometimes be permanent and has a negative impact on a person's look. As a result, a growing number of people are concerned about their aesthetic appearance, and the prevalence of acne also contributes to the expansion of the market.
People in the North American region have shown a growing desire for cosmetic treatments that do not include the use of intrusive techniques. Injectable treatments are becoming more popular among residents of Canada for the purpose of reducing the appearance of scars. In the Canadian market, the high acceptance rate of non-invasive cosmetic treatments also has a significant amount to do with the steps taken by the government. The report of any potential adverse reactions to the cosmetic injectables that a company market is now required by law to be submitted by the company providing the injectables under the jurisdiction of Health Canada.
The US market dominated the North America Scar Treatment Market by Country in 2021; thereby, achieving a market value of $9,524.5 million by 2028. The Canada market is experiencing a CAGR of 10.7% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 9.7% during (2022 - 2028).
Based on End-use, the market is segmented into Hospitals, Clinics, and Retail Pharmacies/ E-commerce. Based on Product, the market is segmented into Topical Products (Creams, Gels, Silicon Sheets, and Others), Laser Products, Injectables, and Others. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Lumenis Be Ltd., Merz Pharma GmbH & Co. KGaA, Cynosure, LLC, Molnlycke Health Care AB (Investor AB), Suneva Medical, Inc., Perrigo Company PLC, Sientra, Inc., Bausch Health Companies, Inc. and Alma Lasers (Sisram Medical Ltd.)
Deeper scars may be treated in a number of different ways, depending on the individual and the circumstances. These procedures may include the use of dermabrasion, excision, laser surgery, or skin transplants. A skin transplant involves the use of skin taken from another part of your body by a surgeon. People who have been burned often get this treatment. Scarring may be a concern for function; however, surgery can assist in addressing the issue and improve function if it's severe enough.
If a person just had surgery that resulted in scarring, it is advised to wait at least a year before deciding how to treat the scars before making any treatment choices. The majority of scars eventually lighten in color and become less apparent as time passes. In addition, the scar markings, like stretch marks and hypertrophic scars, are the ones responsible for the appearance of dwindling. A further factor that helps the expansion of the industry is the growing popularity of skin piercing. It is possible for a keloid scar to develop at the site of the skin piercing.
A further factor that contributes to the expansion of the market is the rising incidence of acne scars. Scarring from face acne may sometimes be permanent and has a negative impact on a person's look. As a result, a growing number of people are concerned about their aesthetic appearance, and the prevalence of acne also contributes to the expansion of the market.
People in the North American region have shown a growing desire for cosmetic treatments that do not include the use of intrusive techniques. Injectable treatments are becoming more popular among residents of Canada for the purpose of reducing the appearance of scars. In the Canadian market, the high acceptance rate of non-invasive cosmetic treatments also has a significant amount to do with the steps taken by the government. The report of any potential adverse reactions to the cosmetic injectables that a company market is now required by law to be submitted by the company providing the injectables under the jurisdiction of Health Canada.
The US market dominated the North America Scar Treatment Market by Country in 2021; thereby, achieving a market value of $9,524.5 million by 2028. The Canada market is experiencing a CAGR of 10.7% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 9.7% during (2022 - 2028).
Based on End-use, the market is segmented into Hospitals, Clinics, and Retail Pharmacies/ E-commerce. Based on Product, the market is segmented into Topical Products (Creams, Gels, Silicon Sheets, and Others), Laser Products, Injectables, and Others. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Lumenis Be Ltd., Merz Pharma GmbH & Co. KGaA, Cynosure, LLC, Molnlycke Health Care AB (Investor AB), Suneva Medical, Inc., Perrigo Company PLC, Sientra, Inc., Bausch Health Companies, Inc. and Alma Lasers (Sisram Medical Ltd.)
Scope of the Study
Market Segments Covered in the Report:
By End-use
- Hospitals
- Clinics
- Retail Pharmacies/ E-commerce
By Product
- Topical Products
- Creams
- Gels
- Silicon Sheets
- Others
- Laser Products
- Injectables
- Others
By Scar Type
- Atrophic Scars
- Hypertrophic & Keloid Scars
- Contracture Scars
- Stretch Marks
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Smith & Nephew PLC
- Lumenis Be Ltd
- Merz Pharma GmbH & Co. KGaA
- Cynosure, LLC
- Molnlycke Health Care AB (Investor AB)
- Suneva Medical, Inc
- Perrigo Company PLC
- Sientra, Inc
- Bausch Health Companies, Inc
- Alma Lasers (Sisram Medical Ltd.)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Scar Treatment Market, by End-use
1.4.2 North America Scar Treatment Market, by Product
1.4.3 North America Scar Treatment Market, by Scar Type
1.4.4 North America Scar Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Scar Treatment Market
Chapter 4. North America Scar Treatment Market by End-use
4.1 North America Hospitals Market by Country
4.2 North America Clinics Market by Country
4.3 North America Retail Pharmacies/ E-commerce Market by Country
Chapter 5. North America Scar Treatment Market by Product
5.1 North America Topical Products Market by Country
5.2 North America Scar Treatment Market by Topical Products Type
5.2.1 North America Creams Market by Country
5.2.2 North America Gels Market by Country
5.2.3 North America Silicon Sheets Market by Country
5.2.4 North America Others Market by Country
5.3 North America Laser Products Market by Country
5.4 North America Injectables Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Scar Treatment Market by Scar Type
6.1 North America Atrophic Scars Market by Country
6.2 North America Hypertrophic & Keloid Scars Market by Country
6.3 North America Contracture Scars Market by Country
6.4 North America Stretch Marks Market by Country
Chapter 7. North America Scar Treatment Market by Country
7.1 US Scar Treatment Market
7.1.1 US Scar Treatment Market by End-use
7.1.2 US Scar Treatment Market by Product
7.1.2.1 US Scar Treatment Market by Topical Products Type
7.1.3 US Scar Treatment Market by Scar Type
7.2 Canada Scar Treatment Market
7.2.1 Canada Scar Treatment Market by End-use
7.2.2 Canada Scar Treatment Market by Product
7.2.2.1 Canada Scar Treatment Market by Topical Products Type
7.2.3 Canada Scar Treatment Market by Scar Type
7.3 Mexico Scar Treatment Market
7.3.1 Mexico Scar Treatment Market by End-use
7.3.2 Mexico Scar Treatment Market by Product
7.3.2.1 Mexico Scar Treatment Market by Topical Products Type
7.3.3 Mexico Scar Treatment Market by Scar Type
7.4 Rest of North America Scar Treatment Market
7.4.1 Rest of North America Scar Treatment Market by End-use
7.4.2 Rest of North America Scar Treatment Market by Product
7.4.2.1 Rest of North America Scar Treatment Market by Topical Products Type
7.4.3 Rest of North America Scar Treatment Market by Scar Type
Chapter 8. Company Profiles
8.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Product Line and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.1.5.2 Acquisitions and Mergers:
8.2 Perrigo Company PLC
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Bausch Health Companies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 Sientra, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Molnlycke Health Care AB (Investor AB)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.6 Smith & Nephew PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional and Segmental Analysis
8.6.4 Research & Development Expense
8.7 Cynosure, LLC
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.7.2.2 Product Launches and Product Expansions:
8.8 Suneva Medical, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 Lumenis Be Ltd.
8.9.1 Company Overview
8.10. Merz Pharma GmbH & Co. KGaA
8.10.1 Company Overview
Companies Mentioned
- Smith & Nephew PLC
- Lumenis Be Ltd.
- Merz Pharma GmbH & Co. KGaA
- Cynosure, LLC
- Molnlycke Health Care AB (Investor AB)
- Suneva Medical, Inc.
- Perrigo Company PLC
- Sientra, Inc.
- Bausch Health Companies, Inc.
- Alma Lasers (Sisram Medical Ltd.)
Methodology
LOADING...
